|
Real-time Estimate
Cboe BZX
19:44:15 14/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 69.40 USD | +0.75% |
|
+6.95% | -15.38% |
| 08-12 | Oppenheimer Adjusts PT on Tarsus Pharmaceuticals to $100 From $97, Keeps Outperform Rating | MT |
| 08-07 | Mizuho Adjusts Tarsus Pharmaceuticals PT to $100 From $98, Maintains Outperform Rating | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
TARS 69.47 $
+0.86%
9.6M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| TARS | 69.47USD | +0.86% | 9.6M $ | |
CBOE
| TARS | 69.30USD | +0.64% | 114K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 70.55 | 77.43 | 81.78 |
| Spread/Res. | -1.91% | -10.63% | -15.38% |
| Spread/Supp. | +23.33% | +23.33% | +40.19% |
| Support | 56.11 | 56.11 | 49.36 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- TARS Stock
- Charts Tarsus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
